MX2022009574A - Polipéptidos modificados derivados de dominio variable de la base pentona de adenovirus. - Google Patents

Polipéptidos modificados derivados de dominio variable de la base pentona de adenovirus.

Info

Publication number
MX2022009574A
MX2022009574A MX2022009574A MX2022009574A MX2022009574A MX 2022009574 A MX2022009574 A MX 2022009574A MX 2022009574 A MX2022009574 A MX 2022009574A MX 2022009574 A MX2022009574 A MX 2022009574A MX 2022009574 A MX2022009574 A MX 2022009574A
Authority
MX
Mexico
Prior art keywords
polypeptide
adenovirus
domain
alpha
fragment
Prior art date
Application number
MX2022009574A
Other languages
English (en)
Spanish (es)
Inventor
Frédéric Garzoni
Original Assignee
Imophoron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imophoron Ltd filed Critical Imophoron Ltd
Publication of MX2022009574A publication Critical patent/MX2022009574A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1055Protein x Protein interaction, e.g. two hybrid selection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/20Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10323Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/10011Adenoviridae
    • C12N2710/10311Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10333Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2022009574A 2020-02-05 2021-02-05 Polipéptidos modificados derivados de dominio variable de la base pentona de adenovirus. MX2022009574A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20155742 2020-02-05
EP20155982 2020-02-06
PCT/EP2021/052884 WO2021156489A1 (en) 2020-02-05 2021-02-05 Engineered polypeptides derived from variable domain of adenovirus penton base

Publications (1)

Publication Number Publication Date
MX2022009574A true MX2022009574A (es) 2022-11-16

Family

ID=74561908

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009574A MX2022009574A (es) 2020-02-05 2021-02-05 Polipéptidos modificados derivados de dominio variable de la base pentona de adenovirus.

Country Status (10)

Country Link
US (1) US20230101439A1 (https=)
EP (1) EP4100421A1 (https=)
JP (1) JP2023513512A (https=)
CN (1) CN115427431A (https=)
AU (1) AU2021216124A1 (https=)
BR (1) BR112022015461A2 (https=)
CA (1) CA3166852A1 (https=)
MX (1) MX2022009574A (https=)
WO (1) WO2021156489A1 (https=)
ZA (1) ZA202209759B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024042100A1 (en) 2022-08-22 2024-02-29 Imophoron Limited Adenovirus penton-based virus-like particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4597188B2 (ja) 2004-03-09 2010-12-15 アイトゲネシシェ・テヒニーシェ・ホッホシューレ・チューリッヒ 多タンパク質適用のための新規発現ツール
JP2012519476A (ja) 2009-03-06 2012-08-30 ヨーロピアン モレキュラー バイオロジー ラボラトリー 多タンパク質複合体のクローニング及び発現のための核酸
PL222497B1 (pl) * 2009-06-26 2016-08-31 Inst Biochemii I Biofizyki Pan Wektorowa cząsteczka wirusopodobna, sposób jej wytwarzania, kompozycja farmaceutyczna oraz zastosowanie wektorowej cząsteczki wirusopodobnej
EP3436591B1 (en) 2016-03-31 2023-01-04 The European Molecular Biology Laboratory Adenoviral coat protein derived delivery vehicles
WO2019016756A1 (en) * 2017-07-21 2019-01-24 Glaxosmithkline Biologicals Sa ANTIGEN CONSTRUCTS OF CHIKUNGUNYA VIRUSES
SG11202100898UA (en) * 2018-07-31 2021-02-25 Imophoron Ltd Multimerizing polypeptides derived from jelly roll fold domain of adenovirus penton base

Also Published As

Publication number Publication date
US20230101439A1 (en) 2023-03-30
WO2021156489A1 (en) 2021-08-12
CN115427431A (zh) 2022-12-02
BR112022015461A2 (pt) 2022-10-11
ZA202209759B (en) 2023-07-26
EP4100421A1 (en) 2022-12-14
AU2021216124A1 (en) 2022-09-29
CA3166852A1 (en) 2021-08-12
JP2023513512A (ja) 2023-03-31

Similar Documents

Publication Publication Date Title
Nakamura et al. Structural basis of filamin A functions
Chen et al. Determination of stereochemistry stability coefficients of amino acid side‐chains in an amphipathic α‐helix
Hackeng et al. Total chemical synthesis of human matrix Gla protein
Weiss et al. Vinculin is part of the cadherin–catenin junctional complex: complex formation between α-catenin and vinculin
RU2004109222A (ru) Слитые белки модифицированного трансферрина
NZ596787A (en) Growth hormone polypeptides and methods of making and using same
Luong et al. Antimicrobial activity and stability of stapled helices of polybia-MP1
EA200201121A1 (ru) Модуляторы рецепторов паратироидного гормона и родственного паратироидному гормону белка
EP4582442A3 (en) Tnfr2 agonists with improved stability
Schmidt et al. Interaction of talin with actin: sensitive modulation of filament crosslinking activity
Hojo et al. Total synthesis and structural characterization of caveolin‐1
MX2022009574A (es) Polipéptidos modificados derivados de dominio variable de la base pentona de adenovirus.
US7262272B2 (en) Polypeptide compositions formed using a coiled-coil template and methods of use
Ustunol Amino acids, peptides, and proteins
WO2002008716A3 (fr) Procede de criblage de peptides utilisables en immunotherapie
Khew et al. Template-assembled triple-helical peptide molecules: mimicry of collagen by molecular architecture and integrin-specific cell adhesion
Gross et al. Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nα‐9‐fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side‐chain and backbone anchoring strategies, and compatible protection for N‐terminal cysteine
Kjaergaard et al. Solution structure of recombinant somatomedin B domain from vitronectin produced in Pichia pastoris
Katritzky et al. Benzotriazole-Assisted Solid-Phase Assembly of Leu-Enkephalin, Amyloid β segment 34− 42, and other “Difficult” Peptide Sequences
Dalcol et al. Convergent synthesis of repeating peptides (Val-X-Leu-Pro-Pro-Pro) 8 adopting a polyproline II conformation
Chen et al. Microwave-assisted acid hydrolysis of proteins combined with peptide fractionation and mass spectrometry analysis for characterizing protein terminal sequences
Doucet et al. Gel formation of peptides produced by extensive enzymatic hydrolysis of β-lactoglobulin
Zhang et al. Oxidative folding of hepcidin at acidic pH
Alloza et al. Cross-linking approach to affinity capture of protein complexes from chaotrope-solubilized cell lysates
EP1191836B1 (en) Polypeptide compositions formed using a coiled-coil template and methods of use